Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports ...

Dexcom is working to replace some of the receivers that link with its continuous glucose monitoring systems due to a ...

DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and ...

I paired my Oura ring with Dexcom's Stelo CGM to track my glucose. Here's what I learned about my eating habits.

The gadget is emblematic of the movement’s emphasis on self-reliance.

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act ...

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DXCM perfectly fits that description, ...

Fintel reports that on June 16, 2025, Truist Securities initiated coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 22.56% Upside As of June 1, 2025, the ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.38, a high estimate of $106.00, and a low estimate of $85.00. Surpassing the previous average price ...